Surgical aspects of neuroendocrine tumours

European Journal of Cancer

Volumn 45, Issue SUPPL. 1, 2009, Pages 237-250

  Åkerström, Göran ^a   Hellman, Per ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYTRYPTOPHAN; 6 FLUORODOPA F 18; ANTINEOPLASTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; GADOTERIC ACID; OCTREOTIDE; PENTETREOTIDE; PROTON PUMP INHIBITOR; RECOMBINANT ALPHA INTERFERON; SOMATOSTATIN DERIVATIVE;

ADULT NESIDIOBLASTOSIS; APPENDECTOMY; APPENDICEAL CARCINOID; APPENDIX TUMOR; ARTICLE; CANCER CLASSIFICATION; CANCER SURGERY; CARCINOID; CHOLECYSTECTOMY; COLON CARCINOID; COLON TUMOR; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DIGESTIVE SYSTEM TUMOR; ENDOCRINE TUMOR; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPY; ENTEROCHROMAFFIN LIKE CELL; FLUID THERAPY; GASTRECTOMY; GASTRIC CARCINOID; GASTRINOMA; GLUCAGONOMA; HEMICOLECTOMY; HUMAN; INSULINOMA; LIVER LOBECTOMY; LIVER METASTASIS; LIVER SURGERY; MALIGNANT INSULINOMA; MIDGUT CARCINOID; MULTIPLE ENDOCRINE NEOPLASIA; NEUROENDOCRINE TUMOR; NONFUNCTIONING ENDOCRINE PANCREATIC TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PANCREAS ISLET CELL TUMOR; PANCREATICODUODENECTOMY; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RECTUM CARCINOID; RECTUM SURGERY; RECTUM TUMOR; STOMACH ANTRUM RESECTION; STOMACH BIOPSY; STOMACH TUMOR; SURGICAL TECHNIQUE; TUMOR LOCALIZATION; TUMOR VOLUME; VIPOMA; ZOLLINGER ELLISON SYNDROME;

GASTRINOMA; GASTROINTESTINAL NEOPLASMS; GLUCAGONOMA; HUMANS; INSULINOMA; LIVER NEOPLASMS; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; REOPERATION; VIPOMA;

EID: 70349134273     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(09)70039-5     Document Type: Article

References (75)

1. Maggard M.A., O'Connell J.B., and Ko C.Y. Updated population-based review of carcinoid tumors. Ann Surg 240 (2004) 117-122
2. Pinchot S.N., Hole K., Sippel R.S., and Chen H. Carcinoid tumors. The Oncologist 13 (2008) 1255-1269
3. Åkerström G., Hellman P., and Hessman O. Gastrointestinal carcinoids. In: Lennard T.W.J. (Ed). Endocrine Surgery (2006), Elsevier, Amsterdam 163-198
4. Modlin I.M., Lye K.D., and Kidd M. A 5-decade analysis of 13,715 carcinoid tumours. Cancer 97 (2003) 934-959
5. Modlin I.M., Kidd M., Latich I., Zikusoka M.N., and Shapiro M.D. Current status of gastrointestinal carcinoids. Gastroenterology 128 (2005) 1717-1751
6. Delle Fave G., Capurso G., Milione M., and Panzuto F. Endocrine tumours of the stomach. Best Pract & Res Clin Gastroenterol 19 (2005) 659-673
7. Ichikawa J., Tanabe S., Koizumi W., et al. Endoscopic mucosal resection in the management of gastric carcinoid tumors. Endoscopy 35 (2003) 203-206
8. Ruszniewski P., Delle Fave G., Cadiot G., et al. Well-differentiated gastric tumors/carcinomas. Neuroendocrinol 84 (2006) 158-164
9. Borch K., Ahrén B., Ahlman H., et al. Gastric carcinoids: Biologic behaviour and prognosis after differentiated treatment in relation to type. Ann Surg 242 (2005) 64-71
10. Ahlman H., Kölby L., Lundell L., et al. Clinical management of gastric carcinoid tumors. Digestion 55 suppl 3 (1994) 77-85
11. Bordi C., Corleto V.D., Azzoni C., et al. The antral mucosa as a new site for endocrine tumors in multiple endocrine neoplasia typea 1 and Zollinger-Ellison syndromes. J Clin Endocrinol Metab 86 (2001) 2236-2242
12. Bordi C., Falchetti A., Azzoni C., et al. Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I. Am J Surg Pathol 21 (1997) 1075-1082
13. Richards M.L., Gauger P., Thompson N.W., and Giordano T.J. Regression of type II gastric carcinoid in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas. World J Surg 28 (2004) 652-658
14. Norton J.A., Melcher M.L., Gibril F., and Jensen R.T. Gastric carcinoids tumors in multiple endocrine neoplasia-1 patients with Zollinger-Ellison syndrome can be symptomatic, demonstrate aggressive growth, and require surgical treatment. Surgery 136 (2004) 1267-1274
15. Shinohara T., Ohyama S., Nagano H., et al. Minute gastric carcinoid tumor with regional lymph node metastasis. Gastric Cancer 6 (2003) 262-266
16. Wilander E., El-Salhy M., and Pitkänen P. Histopathology of gastric carcinoids: a survey of 42 cases. Histopathology 8 (1984) 183-193
17. Rindi G., Bordi C., Rappel S., La Rosa S., Stolte M., and Solcia E. Gastric carcinoids and neuroendocrine carcinomas: Pathogenesis, pathology and behavior. World J Surg 20 (1996) 168-172
18. Rindi G., Azzoni C., La Rosa S., et al. ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology 116 (1999) 532-542
19. Makridis C., Öberg K., Juhlin C., et al. Surgical treatment of mid-gut carcinoids tumors. World J Surg 14 (1990) 377-385
20. Öhrvall U., Eriksson B., Juhlin C., et al. Method of dissection of mesenteric metastases in mid-gut carcinoid tumors. World J Surg 24 (2000) 1402-1408
21. Eriksson B., Klöppel G., Krenning E., et al. Consensus guidelines for the management of patients with digestive neuroendocrine tumors - well-differentiated jejunal-ileal tumor/carcinoma. Neuroendocrinol 87 (2008) 8-19
22. Makridis C., Rastad J., Öberg K., and Åkerström G. Progression of metastases and symptom improvement from laparotomy in midgut carcinoid tumors. World J Surg 20 (1996) 900-907
23. Makridis C., Ekbom A., Bring J., et al. Survival and daily physical activity in patients treated for advanced midgut carcinoid tumors. Surgery 122 (1997) 1075-1082
24. Åkerström G., Kianmanesh R., Falconi M., and Plöckinger U. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumours: Pre-and perioperative therapy in patients with neuroendocrine tumours. Neuroendocrinology 90 (2009) 203-208
25. Hellman P., Lundström T., Öhrvall U., et al. Effect of surgery on the outcome of midgut carcinoids disease with lymph node and liver metastases. World J Surg 26 (2002) 991-997
26. Goede A.C., Caplin M.E., and Winslet M.C. Carcinoid tumor of the appendix. Br J Surg 90 (2003) 1317-1322
27. Stinner B., and Rothmund M. Neuroendocrine tumours (carcinoids) of the appendix. Best Pract & Res Clin Gastroenterol 19 (2005) 729-738
28. Plöckinger U., Couvelard A., Falconi M., et al. Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated tumour/carcinoma of the appendix and goblet cell carcinoma. Neuroendocrinol 87 (2008) 20-30
29. Ballantyne G.H., Savoca P.E., Flannery J.T., Ahlman M.H., and Modlin I.M. Incidence and mortality of carcinoids of the colon. Data from the Connecticut Tumor Registry. Cancer 69 (1992) 2400-2405
30. Vogelsang H., and Siewert J.R. Endocrine tumours of the hindgut. Best Pract & Res Clin Gastroenterol 19 (2005) 739-752
31. Ramage J.K., Goretzki P.E., Manfredi R., et al. Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated colon and rectum tumour/carcinoma. Neuroendocrinol 87 (2008) 31-39
32. Koura A.N., Giacco G.G., Curley S.A., Skibber J.M., Feig B.W., and Ellis L.M. Carcinoid tumors of the rectum: effect of size, histopathology and surgical treatment on metastasis free survival. Cancer 79 (1997) 1294-1298
33. Suzuki H., and Ikeda K. Endoscopic mucosal resection and full thickness resection with complete defect closure for early gastrointestinal malignancies. Endoscopy 33 (2001) 437-439
34. Nakagoe T., Ishikawa H., Sawai T., et al. Gasless video endoscopic transanal excision of rectal tumors incompletely removed by colonoscopic snare polypectomy. J Laparoendosc Adv Surg Tech 13 (2003) 99-103
35. Åkerström G., Hellman P., Hessman O., and Osmak L. Surgical treatment of endocrine pancreatic tumours. Neuroendocrinology 80 suppl 1 (2004) 62-66
36. Scarlett J.A., Mako M.E., Rubenstein A.H., et al. Factitious hypoglycemia: diagnosis by measurement of serum C-peptide immunoreactivity and insulin-binding antibodies. N Engl J Med 297 (1977) 1029-1032
37. Metz D.C., and Jensen R.T. Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. Gastroenterology 135 (2008) 1469-1492
38. de Herder W.W., Niederle B., Scoazec J.-Y., et al. Welle-differentiated pancreatic tumor/carcinoma: Insulinoma. Neuroendocrinol 84 (2006) 183-188
39. Thompson N.W., Czako P.F., Fritts L.L., et al. Role of endoscopic ultrasonography in the localization of insulinomas and gastrinomas. Surgery 116 (1994) 1131-1138
40. Anderson M.A., Carpenter S., Thompson N.W., Nostrant T.T., Elta G.H., and Scheiman J.M. Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas. Am J Gastroenterol 95 (2000) 2271-2277
41. Doppman J.L., Chang R., Fraker D.L., et al. Localization of insulinomas to regions of the pancreas by intra-arterial stimulation with calcium. Ann Intern Med 123 (1995) 269-273
42. Grant C.S. Insulinoma. Best Pract & Res Clin Gastroenterol 19 (2005) 783-798
43. Service G.J., Thompson G.B., Service F.J., Andrews J.C., Collazo-Clavell M.L., and Lloyd R.V. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med 353 (2005) 249-254
44. Won J.G.S., Tseng H.-S., Yang A.-H., et al. Clinical features and morphological characterization of 10 patients with noninsulinoma pancreatogenous hypoglycemia syndrome (NIPHS). Clin Endocrinol 65 (2006) 566-578
45. Jensen R.T., Niederle B., Mitry E., et al. Gastrinoma (duodenal and pancreatic). Neuroendocrinol 84 (2006) 173-182
46. Imamura M., and Takahashi K. Use of selective arterial secretin injection test to guide surgery in patients with Zollinger-Ellison syndrome. World J Surg 17 (1993) 433-438
47. Norton J.A., Fraker D.L., and Alexander H.R. Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 341 (1999) 635-644
48. Yu F., Venzon D.J., Serrano J., et al. Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison Syndrome. J Clin Oncol 17 (1999) 615-630
49. Doherty G.M. Rare endocrine tumours of the GI tract. Best Pract & Res Clin Gastroenterol 19 (2005) 807-818
50. Hellman P., Andersson M., Rastad J., et al. Surgical strategy for large or malignant endocrine pancreatic tumours. World J Surg 24 (2000) 1353-1360
51. Bartsch D.K., Schilling T., Ramaswamy A., et al. Management of nonfunctioning isle cell carcinomas. World J Surg 24 (2000) 1418-1424
52. Kouvaraki M.A., Solorzano C.C., Shapiro S.E., et al. Surgical treatment of non-functioning pancreatic islet cell tumors. J Surg Oncol 89 (2005) 170-185
53. Öberg K., and Eriksson B. Endocrine tumours of the pancreas. Best Pract & Res Clin Gastroenterol 19 (2005) 753-782
54. Falconi M., Plöckinger U., Kwekkebom, et al. Welle-differentiated pancreatic non-functioning tumors/carcinoma. Neuroendocrinol 84 (2006) 196-211
55. Åkerström G., Hessman O., Hellman P., and Skogseid B. Pancreatic tumours as part of the MEN-1 syndrome. Best Pract & Res Clin Gastroenterol 19 (2005) 819-830
56. Doherty G.M., Olson J.A., Frisella M.M., Lairmore T.C., Wells Jr. S.A., and Norton J.A. Lethality of multiple endocrine neoplasia type 1. World J Surg 22 (1998) 581-587
57. Dean P.G., van Heerden J.A., Farley D.R., et al. Are patients with multiple endocrine neoplasia type 1 prone to premature death?. World J Surg 1 (2000) 1437-1441
58. Skogseid B., Rastad J., and Åkerström G. Pancreatic endocrine tumors in multiple endocrine neooplasia type 1. In: Doherty G., and Skogseid B. (Eds). Surgical Endocrinology (2001), Lippincott, Williams & Wilkins, Philadelphia, PA 511-525
59. Norton J.A. Surgical treatment and prognosis of gastrinoma. Best Pract & Res Clin Gastroenterol 19 (2005) 799-805
60. Gauger P.G., Scheiman J.M., Wamsteker E.-M., Richards M.L., Doherty G.M., and Thompson N.W. Role of endoscopic ultrasound in screening and treatment of pancreatic endocrine tumours in asymptomatic patients with multiple endocrine neoplasia type 1. Br J Surg 90 (2003) 748-754
61. Hellman P., Hennings J., Åkerström G., and Skogseid B. Endoscopic ultrasonography for evaluation of pancreatic tumours in multiple endocrine neoplasia type 1. Br J Surg 92 (2005) 1508-1512
62. Doherty G.M. Multiple endocrine neoplasia type 1: duodenopan-creatic tumors. Surgical Oncology 12 (2003) 135-143
63. Triponez F., Goudet P., Dosseh D., et al. Is surgery beneficial for MEN 1 patients with small (≤2 cm), nonfunctioning pancreaticoduodenal endocrine tumor? An analysis of 65 patients from the GTE. World J Surg 30 (2006) 654-662
64. You Y.N., Thompson G.B., Young W.F., et al. Pancreatoduodenal surgery in patients with multiple endocrine neoplasia type 1: Operative outcomes, long-term function, and quality of life. Surgery 142 (2007) 829-836
65. Kouvaraki M.A., Shapiro S.E., Cote G.J., et al. Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1. World J. Surg 30 (2006) 643-653
66. Bartsch D.K., Fendrich V., Langer P., et al. Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1. Ann. Surg 242 (2005) 757-766
67. Wängberg B., Westberg G., Tylén U., et al. Survival of patients with disseminated midgut carcinoid tumors after aggressive tumor reduction. World J Surg 20 (1996) 892-899
68. Nave H., Mössinger E., Feist H., Lang H., and Raab H. Surgery as primary treatment in patients with liver metastases from carcinoid tumors: A retrospective, unicentric study over 13 years. Surgery 129 (2001) 170-175
69. Elias D., Lasser P., Ducreux M., et al. Liver resection (and associated extrahepatic resections) for metastatic well-diferentiated endocrine tumors: A 15-year single center prospective study. Surgery 133 (2003) 375-382
70. Norton J.A., Warren R.S., Kelly M.F., Zuraek M.B., and Jensen R.T. Aggressive surgery for metastatic liver neuroendocrine tumors. Surgery 134 (2003) 1057-1065
71. Touzios J.G., Kiely J.M., Pitt S.C., et al. Neuroendocrine hepatic metastases. Does aggressive management improve survival?. Ann Surg 241 (2005) 776-785
72. Landry C.S., Scoggins C.R., Mcmasters K.M., and Martin II R.C.G. Management of hepatic metastasis of gastrointestinal carcinoid tumors. J Surg Oncol 97 (2008) 253-258
73. Steinmüller T., Kianmanesh R., Falconi M., et al. Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumours: foregut, midgut, hindgut, and unknown primary. Neuroendocrinol 87 (2008) 42-62
74. Frillling A., Li J., Malamutmann E., Schmid K.-W., Bockisch A., and Broelsch C.E. Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease. Br J Surg 96 (2009) 175-184
75. Hellman P., Ladjevardi S., Skogseid B., Åkerström G., and Elvin A. Radiofrequency tissue ablation using cooled tip for liver metastases of endocrine tumors. World J Surg 26 (2002) 1052-1056